Related Experiment Video
Updated: Jun 15, 2026

06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
Reference Values for the Revised Anti-Müllerian Hormone Generation II Assay: Infertile Population-based Study
Joong Yeup Lee1, Soyeon Ahn2, Jung Ryeol Lee3
1Hamchoon Women's Clinic, Seoul, Korea.
Journal of Korean Medical Science
|April 6, 2017
Summary
This study establishes population-based reference values for Anti-Müllerian hormone (AMH) using the revised Gen II assay. These new AMH reference values aid in more accurate ovarian reserve estimation for infertile women.
Area of Science:
- Reproductive Endocrinology
- Clinical Biochemistry
- Infertility Research
Background:
- Anti-Müllerian hormone (AMH) is a key clinical marker for assessing ovarian reserve.
- AMH testing is a common initial step in infertility evaluations.
- Establishing reliable reference values is crucial for accurate interpretation.
Purpose of the Study:
- To establish population-based reference values for AMH using the revised second generation (Gen II) assay.
- To develop and validate AMH-age regression models for infertile women.
- To provide updated centile charts for AMH levels based on age.
Main Methods:
- Population-based cohort study involving 15,801 infertile women aged 25-45 years.
- AMH levels were measured using the revised Gen II assay.
- Five AMH-age regression models were established and validated, with a quadratic model identified as optimal.
Main Results:
- A quadratic regression model (log AMH = 0.410 × age -0.008 × age² -3.791) best described the age-related decline in AMH.
- The study generated age-specific reference values and centile charts for AMH.
- This represents the largest population-based dataset for establishing AMH reference values with the revised Gen II assay.
Conclusions:
- The established AMH reference values, derived from a large population, enhance the accuracy of ovarian reserve estimation.
- The revised Gen II assay and the developed models provide a more precise tool for clinical practice.
- These findings support improved diagnostic capabilities in infertility management.

